Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2004 Nov;12(11):797-804.
doi: 10.1007/s00520-004-0677-3.

Discrepant views of oncologists and cancer patients on complementary/alternative medicine

Affiliations
Comparative Study

Discrepant views of oncologists and cancer patients on complementary/alternative medicine

Mary Ann Richardson et al. Support Care Cancer. 2004 Nov.

Abstract

Goals: Complementary/ alternative medicine (CAM) is widely used by patients but rarely discussed with oncologists. To understand reasons for the communication gap, this study compares physicians and patients on perceived reasons for CAM use and nondisclosure of use, reactions of physicians to disclosure, and expectations for CAM.

Patients and methods: Cross-sectional studies assessed 82 physicians (response 68.3%) and 244 of 374 outpatients (response 65.2%) identified as CAM users at the MD Anderson Cancer Center. Data were summarized by frequency and compared using chi-square tests.

Main results: Physicians were more likely (p<0.001) than patients to attribute CAM use to hope (chi2=17.7), control (chi2=17.5), incurable disease (chi2=42.8), or a nontoxic approach (chi2=50.9). Both physicians and patients agreed CAM could relieve symptoms/side effects, but physicians were less likely (p<0.001) than patients to expect that CAM improved immunity (chi2=72.2) or quality of life (chi2=17.1), cured disease (chi2=42.5), or prolonged life (chi2=58.4). Physicians and patients responded differently (p<0.005) on reasons for nondisclosure. Physicians believed patients felt CAM discussions were unimportant (chi2=7.9) and physicians would not understand (chi2 =48.1), discontinue treatment (chi2=26.4), discourage or disapprove of the use (chi2=131.7); patients attributed nondisclosure to their uncertainty of its benefit (chi2=10.4) and never being asked about CAM (chi2=9.9) by physicians. Physicians were more likely (chi2=9.5, p<0.002) to warn of risks and less likely (chi2=23.5, p<0.001) to encourage use than patients perceived.

Conclusion: Oncologists and cancer patients hold discrepant views on CAM that may contribute to a communication gap. Nevertheless, physicians should ask patients about CAM use, discuss possible benefits, and advise of potential risks.

PubMed Disclaimer

References

    1. J Clin Oncol. 2003 Mar 1;21(5):932-6 - PubMed
    1. Hawaii Med J. 1999 Apr;58(4):94-8 - PubMed
    1. CA Cancer J Clin. 1992 May-Jun;42(3):181-91 - PubMed
    1. Support Care Cancer. 2000 Jul;8(4):314-22 - PubMed
    1. J Clin Oncol. 2002 Mar 15;20(6):1473-9 - PubMed

Publication types

MeSH terms

LinkOut - more resources